Health
Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting – News-Medical.Net
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance…
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th…
Continue Reading
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Business15 hours agoSolid superannuation gains continue to roll in
-
Noosa News13 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Noosa News15 hours agoBoy charged over E-Bike crash